Shengtai Pharmaceutical Inc., (OTC BB: SGTI) is China’s leading manufacturer and supplier of pharmaceutical grade glucose for medicinal purposes. In addition to their pharmaceutical glucose series of products, they also produce other medicinal product lines as well such as industrial glucose, syrup, starch, avermectins, dextrin, maltose and maltitol, which are used for food, beverage and industrial production. Based in China, Shengtai has an international client-base. For further information, visit the company website at: www.shengtaipharmaceutical.com.
- 17 years ago
QualityStocks
Shengtai Pharmaceutical Inc., (OTC BB: SGTI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) was awarded an additional $18.4 million funding from the…
-
QualityStocksNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) CEO Shares Bold Strategy on Exploring Mining Podcast
ESGold (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) was recently featured on the Exploring Mining podcast, where new CEO…
-
QualityStocksNewsBreaks – Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Advances Integrated Approach in Broader Growth Strategy
Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF) recently took a significant step in fostering industry collaboration and…